Insiders · PAHC

PAHC insider transactions

Phibro Animal Health Corporation (PAHC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PAHC insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Phibro Animal Health Corporation, latest first. Follow anyone to get their next filing.

• Glenn DavidChief Financial Officer, since February 2024
• Larry Lee MillerChief Operating Officer-$459K
• Patrick RodriguezVP Finance and Treasurer, since January 2026
• Jonathan BendheimDirector
• Judith WeinsteinOfficer, since July 2023
• Jack BendheimExecutive Chairman, Director, 10% owner-$32M
• Lisa Ann EscuderoOfficer
• Daniel M BendheimPresident and CEO, Director
• E Thomas CorcoranDirector+$647K
• Anthony AndolinoOfficer
• Joyce J. LeeDirector, since January 2025
• Alejandro BernalDirector, since February 2023

Recent Form 3, 4, and 5 filings for PAHC

• 53d
  Amendment: Chief Financial Officer David Glenn was granted 3,482 shares, increasing direct ownership by 7% to 54,959 units (SEC Form 4)

  4/A - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 53d
  Amendment: Chief Operating Officer Miller Larry Lee was granted 3,726 shares, increasing direct ownership by 11% to 38,275 units (SEC Form 4)

  4/A - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  VP Finance and Treasurer Rodriguez Patrick was granted 1,503 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  Chief Financial Officer David Glenn was granted 3,334 shares, increasing direct ownership by 6% to 54,811 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  Chief Operating Officer Miller Larry Lee was granted 3,522 shares, increasing direct ownership by 10% to 38,071 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  Director Bendheim Jonathan was granted 2,716 shares, increasing direct ownership by 83% to 5,984 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  Officer Weinstein Judith was granted 2,478 shares, increasing direct ownership by 83% to 5,453 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  Executive Chairman Bendheim Jack was granted 12,103 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  President and CEO Bendheim Daniel M was granted 11,699 shares, increasing direct ownership by 336% to 15,177 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 91d
  Officer Escudero Lisa Ann was granted 1,547 shares, increasing direct ownership by 82% to 3,434 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 95d
  Executive Chairman Bendheim Jack disposed of $84,287 worth of shares (2,303 units at $36.60) (SEC Form 4) to cover withholding tax

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 95d
  Officer Escudero Lisa Ann disposed of $9,699 worth of shares (265 units at $36.60), decreasing direct ownership by 12% to 1,887 units (SEC Form 4) to satisfy withholding obligation

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 95d
  Chief Operating Officer Miller Larry Lee disposed of $23,240 worth of shares (635 units at $36.60), decreasing direct ownership by 2% to 34,549 units (SEC Form 4) (tax liability)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 95d
  Officer Weinstein Judith disposed of $17,275 worth of shares (472 units at $36.60), decreasing direct ownership by 14% to 2,975 units (SEC Form 4) to cover withholding tax

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 95d
  Chief Financial Officer David Glenn disposed of $30,743 worth of shares (840 units at $36.60), decreasing direct ownership by 2% to 51,477 units (SEC Form 4) to satisfy tax liability

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 95d
  President and CEO Bendheim Daniel M disposed of $17,787 worth of shares (486 units at $36.60), decreasing direct ownership by 12% to 3,478 units (SEC Form 4) to satisfy tax liability

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 130d
  SEC Form 4 filed by President and CEO Bendheim Daniel M

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 160d
  Director Corcoran E Thomas bought $317,700 worth of shares (10,000 units at $31.77), increasing direct ownership by 32% to 41,459 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 186d
  President and CEO Bendheim Jack sold $1,016,228 worth of shares (18,608 units at $54.61) as part of a pre-agreed trading plan (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 193d
  President and CEO Bendheim Jack sold $1,137,593 worth of shares (21,120 units at $53.86) as part of a pre-agreed trading plan (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 200d
  President and CEO Bendheim Jack sold $1,157,091 worth of shares (21,120 units at $54.79) as part of a pre-agreed trading plan (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 207d
  SEC Form 4 filed by Bendheim Jack

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 223d
  SEC Form 4 filed by Bendheim Jack

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 228d
  SEC Form 4 filed by Bendheim Jack

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 235d
  SEC Form 4 filed by Bendheim Jack

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 238d
  President and CEO Bendheim Jack converted options into 100,000 shares and sold $258,245 worth of shares (5,280 units at $48.91) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 256d
  President and CEO Bendheim Jack sold $1,103,938 worth of shares (21,120 units at $52.27) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 259d
  President and CEO Bendheim Jack sold $715,775 worth of shares (14,080 units at $50.84) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 264d
  President and CEO Bendheim Jack sold $727,646 worth of shares (14,080 units at $51.68) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 271d
  President and CEO Bendheim Jack sold $3,737,711 worth of shares (72,198 units at $51.77) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 271d
  Chief Financial Officer David Glenn converted options into 30,000 shares and disposed of $646,758 worth of shares (12,528 units at $51.62), increasing direct ownership by 50% to 52,317 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 273d
  President and CEO Bendheim Jack converted options into 185,000 shares and sold $5,362,103 worth of shares (110,842 units at $48.38) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 277d
  President and CEO Bendheim Jack converted options into 30,000 shares and sold $545,473 worth of shares (13,180 units at $41.39) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 280d
  President and CEO Bendheim Jack sold $540,037 worth of shares (13,465 units at $40.11) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 286d
  President and CEO Bendheim Jack sold $50,084 worth of shares (1,235 units at $40.55) and converted options into 30,000 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 291d
  President and CEO Bendheim Jack sold $1,164,547 worth of shares (27,845 units at $41.82) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 291d
  SEC Form 3 filed by new insider Rodriguez Patrick

  3 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 298d
  President and CEO Bendheim Jack sold $569,753 worth of shares (14,134 units at $40.31) and converted options into 20,000 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 300d
  President and CEO Bendheim Jack sold $8,554 worth of shares (213 units at $40.16) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 305d
  President and CEO Bendheim Jack sold $13,149 worth of shares (328 units at $40.09) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 329d
  President and CEO Bendheim Jack sold $235,405 worth of shares (5,752 units at $40.93) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 334d
  President and CEO Bendheim Jack sold $192,781 worth of shares (4,808 units at $40.10) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 340d
  President and CEO Bendheim Jack converted options into 30,000 shares and sold $288,607 worth of shares (7,040 units at $41.00) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 342d
  President and CEO Bendheim Jack sold $296,376 worth of shares (7,040 units at $42.10) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 348d
  President and CEO Bendheim Jack sold $541,674 worth of shares (12,320 units at $43.97) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 350d
  President and CEO Bendheim Jack sold $147,002 worth of shares (3,520 units at $41.76) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 356d
  President and CEO Bendheim Jack converted options into 55,000 shares and sold $466,631 worth of shares (10,560 units at $44.19) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 361d
  President and CEO Bendheim Jack converted options into 15,000 shares and sold $1,365,393 worth of shares (30,337 units at $45.01) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 364d
  President and CEO Bendheim Jack sold $1,885,618 worth of shares (41,823 units at $45.09) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 368d
  President and CEO Bendheim Jack converted options into 25,000 shares and sold $296,778 worth of shares (7,040 units at $42.16) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 375d
  President and CEO Bendheim Jack sold $437,487 worth of shares (10,560 units at $41.43) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 381d
  President and CEO Bendheim Jack sold $765,941 worth of shares (18,899 units at $40.53) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 384d
  President and CEO Bendheim Jack sold $677,198 worth of shares (16,775 units at $40.37) and converted options into 50,000 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 404d
  President and CEO Bendheim Jack sold $834,412 worth of shares (20,664 units at $40.38) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 413d
  President and CEO Bendheim Jack sold $282,732 worth of shares (7,022 units at $40.26) and converted options into 30,000 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 424d
  President and CEO Bendheim Jack sold $857,313 worth of shares (21,120 units at $40.59) (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 447d
  Chief Operating Officer Miller Larry Lee was granted 5,184 shares, increasing direct ownership by 17% to 35,184 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 447d
  Officer Weinstein Judith was granted 3,447 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 447d
  Chief Financial Officer David Glenn was granted 4,845 shares, increasing direct ownership by 16% to 34,845 units (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)
• 447d
  Director Bendheim Jonathan was granted 3,268 shares (SEC Form 4)

  4 - PHIBRO ANIMAL HEALTH CORP (0001069899) (Issuer)